EcoDrugPlus

Solute Carrier Family 6 Member 3

Ensembl ID : ENSCPOG00000024044
Gene Symbol: SLC6A3
2 Cross references
167 Possible Orthologues:

Solute Carrier Family 6 Member 4

Ensembl ID : ENSCPOG00000010596
Gene Symbol: SLC6A4
2 Cross references
204 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSCPOG00000013598
Gene Symbol: SLC6A9
4 Cross references
207 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSCPOG00000005992
Gene Symbol: SLC9A3
4 Cross references
238 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSCPOG00000003720
Gene Symbol: SSTR1
2 Cross references
160 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSCPOG00000033008
Gene Symbol: SSTR2
3 Cross references
263 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSCPOG00000033623
Gene Symbol: SSTR3
4 Cross references
251 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSCPOG00000022586
Gene Symbol: SSTR5
2 Cross references
257 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSCPOG00000035448
Gene Symbol: SPHK2
2 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSCPOG00000040695
Gene Symbol: S1PR1
4 Cross references
194 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSCPOG00000010410
Gene Symbol: SYK
2 Cross references
203 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSCPOG00000023716
Gene Symbol: SRD5A2
4 Cross references
266 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).